Marshall Wace’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-592,874
Closed -$6.09M 2818
2023
Q2
$6.09M Hold
592,874
0.01% 935
2023
Q1
$6.01M Hold
592,874
0.01% 905
2022
Q4
$5.88M Sell
592,874
-3,338
-0.6% -$32.8K 0.01% 1097
2022
Q3
$5.81M Buy
596,212
+3,338
+0.6% +$32.5K 0.01% 1265
2022
Q2
$5.74M Buy
592,874
+100
+0% +$969 0.01% 1242
2022
Q1
$5.73M Hold
592,774
0.01% 1261
2021
Q4
$5.75M Buy
+592,774
New +$5.75M 0.01% 1260

Other funds holding HWEL

Marshall Wace's HWEL Position: Q3 2023 in Review

Marshall Wace sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q3 2023, closing a stake of 592,874 shares — an estimated $6.09M sold.

Marshall Wace first reported a position in HWEL in Q4 2021 and held it in 7 quarters. The position peaked at $6.09M in Q2 2023. 11 funds tracked by Wall St. Rank hold HWEL as of Q3 2023.

  • Marshall Wace reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 592,874 Healthwell Acquisition Corp. I Class A Common Stock shares in Q3 2023, an estimated $6.09M.
  • Marshall Wace first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 7 quarters.
  • Marshall Wace's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $6.09M in Q2 2023.
  • 11 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.